Company Description
Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally.
The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM).
It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.
The company’s Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market.
It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories.
The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019.
Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
| Country | United States |
| Founded | 1982 |
| IPO Date | Jan 1, 1987 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 252 |
| CEO | Charles Goodwin |
Contact Details
Address: 5115 Ulmerton Road Clearwater, Florida 33760-4004 United States | |
| Phone | 727 384 2323 |
| Website | apyxmedical.com |
Stock Details
| Ticker Symbol | APYX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000719135 |
| CUSIP Number | 03837C106 |
| ISIN Number | US03837C1062 |
| Employer ID | 11-2644611 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Charles D. Goodwin II | President, Chief Executive Officer and Director |
| Matthew C. Hill CPA | Chief Financial Officer, Treasurer and Secretary |
| Moshe Citronowicz | Senior Vice President |
| Todd Hornsby | Executive Vice President |
| Stavros George Vizirgianakis B.Com. | Executive Chairman |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 8, 2024 | 10-Q | Quarterly Report |
| Nov 8, 2024 | 424B5 | Filing |
| Nov 8, 2024 | 8-K | Current Report |
| Oct 31, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Oct 15, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Aug 12, 2024 | 8-K | Current Report |
| Aug 8, 2024 | 10-Q | Quarterly Report |
| Aug 8, 2024 | 8-K | Current Report |
| Jun 25, 2024 | DEF 14A | Other definitive proxy statements |
| May 31, 2024 | SD | Form - SD |